UPDATE 2-Fosun Pharma sounds HK deal warning with low IPO price

HONG KONG, Oct 24 (Reuters) – Shanghai Fosun Pharmaceutical (Group) Co Ltd priced Hong Kong’s largest public offering in three months at the bottom of the range on Wednesday to raise about $512 million, a further sign of tough times for new listings.